Register entry
- Registered sites
- 1
- Active NDC listings
- 16
- Labeller names
- 2
- Live patents
- 2
- Countries
- 1
- Base
- Poland
Authorisation
Registered operations
Analytical testing1Labelling1Finished drug manufacture1Packaging1sterilize1
Sites
Registered establishments
1| Establishment | Address | Registered for | FEI / DUNS |
|---|---|---|---|
| STERISCIENCE SP Z O O | Ul Daniszewska 10, Warszawa, Mazowieckie 03-230, Poland (POL) | Analytical testing, Labelling, Finished drug manufacture, Packaging, sterilize | 3009685660522218056 |
Catalogue
Drug listings by form and route
1616 active NDC listings: 16 human prescription drug. By marketing category: ANDA 15, NDA 1.
| Dosage form | NDCs |
|---|---|
| injection, solution | 8 |
| injection, powder, lyophilized, for solution | 5 |
| solution | 2 |
| injection | 1 |
| Route | NDCs |
|---|---|
| intravenous | 15 |
| intramuscular | 5 |
| Labeller name on the listing | NDCs |
|---|---|
| steriscience specialties private limited | 8 |
| steriscience specialties private limited | 8 |
Exclusivity
Patents and exclusivities
2| Patent | Product | Covers | Expiry |
|---|---|---|---|
| 11065265 | FOCINVEZfosaprepitant dimeglumine | product | Jan 2039 |
| 12042504 | FOCINVEZfosaprepitant dimeglumine | product | Jan 2039 |
Catalogue
Marketed products
16| Brand | Generic name | Form / route | NDC |
|---|---|---|---|
| Doxycycline | Doxycycline | injection, powder, lyophilized, for solution, intravenous | 82449-008ANDA |
| FOCINVEZ | FOSAPREPITANT DIMEGLUMINE | injection, intravenous | 82449-231NDA |
| Methylene blue | Methylene Blue | injection, solution, intravenous | 82449-002ANDA |
| Methylene blue | Methylene Blue | injection, solution, intravenous | 82449-003ANDA |
| Midazolam | midazolam hydrochloride | injection, solution, intramuscular, intravenous | 82449-207ANDA |
| Midazolam | midazolam hydrochloride | injection, solution, intramuscular, intravenous | 82449-208ANDA |
| Midazolam | midazolam hydrochloride | injection, solution, intramuscular, intravenous | 82449-209ANDA |
| Rocuronium Bromide | Rocuronium Bromide | injection, solution, intravenous | 82449-001ANDA |
| SUGAMMADEX SODIUM | SUGAMMADEX SODIUM | solution, intravenous | 82449-241ANDA |
| SUGAMMADEX SODIUM | SUGAMMADEX SODIUM | solution, intravenous | 82449-242ANDA |
| Sodium Bicarbonate | SODIUM BICARBONATE | injection, solution, intravenous | 82449-000ANDA |
| Succinylcholine Chloride | Succinylcholine Chloride | injection, solution, intramuscular, intravenous | 82449-232ANDA |
| Vancomycin Hydrochloride | Vancomycin Hydrochloride | injection, powder, lyophilized, for solution, intravenous | 82449-005ANDA |
| Vancomycin Hydrochloride | Vancomycin Hydrochloride | injection, powder, lyophilized, for solution, intravenous | 82449-006ANDA |
| Vancomycin Hydrochloride | Vancomycin Hydrochloride | injection, powder, lyophilized, for solution, intravenous | 82449-007ANDA |
| Ziprasidone Mesylate | ziprasidone mesylate | injection, powder, lyophilized, for solution, intramuscular | 82449-004ANDA |
Compare
Comparable companies in Poland
- NOBILUS ENT TOMASZ KOZLUK1 site · 3 NDC
- FARMINA SP Z O O1 site · 1 NDC
- Polpharma Biologics S.A.2 sites · 1 NDC
Enquiry
Common questions
- Is STERISCIENCE SP Z O O FDA approved?
- STERISCIENCE SP Z O O holds 1 FDA-registered establishment in Poland. Registration puts a site on the FDA's register and open to inspection; it is not an approval of the company. Approvals attach to individual drug applications.
- Where are STERISCIENCE SP Z O O's drugs manufactured?
- The FDA register lists Warszawa. Registered operations: analytical testing, labelling, finished drug manufacture, packaging, sterilize.
- What drugs does STERISCIENCE SP Z O O make?
- 16 products are listed under STERISCIENCE SP Z O O in the openFDA NDC Directory, most often as injection, solution; injection, powder, lyophilized, for solution; solution. The full breakdown by dosage form and route is above. A listing count is not a sales figure.
Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.